Thiolated nanocarriers for oral delivery of hydrophilic macromolecular drugs - PubMed (original) (raw)
Thiolated nanocarriers for oral delivery of hydrophilic macromolecular drugs
S Dünnhaupt et al. Carbohydr Polym. 2015.
Abstract
It was the aim of this study to investigate the effect of unmodified as well as thiolated anionic poly(acrylic acid) (PAA) and cationic chitosan (CS) utilized in free-soluble form and as nanoparticulate system on the absorption of the hydrophilic compound FD4 across intestinal epithelial cell layer with and without a mucus layer. Modifications of these polymers were achieved by conjugation with cysteine to PAA (PAA-Cys) and thioglycolic acid to CS (CS-TGA). Particles were prepared via ionic gelation and characterized based on their amount of thiol groups, particle size and zeta potential. Effects on the cell layer concerning absorption enhancement, transepithelial electrical resistance (TEER) and cytotoxicity were investigated. Permeation enhancement was evaluated with respect to in vitro transport of FD4 across Caco-2 cells, while mucoadhesion was indirectly examined in terms of adsorption behaviour when cells were covered with a mucus layer. Lyophilized particles displayed around 1000 μmol/g of free thiol groups, particle sizes of less than 300 nm and a zeta potential of 18 mV (CS-TGA) and -14 mV (PAA-Cys). Cytotoxicity studies confirmed that all polymer samples were used at nontoxic concentrations (0.5% m/v). Permeation studies revealed that all thiolated formulations had pronounced effects on the paracellular permeability of mucus-free Caco-2 layers and enhanced the permeation of FD4 3.0- to 5.3-fold. Moreover, polymers administered as particles showed a higher permeation enhancement than their corresponding solutions. However, the absorption-enhancing effect of each thiolated formulation was significantly (p<0.05) reduced when cells were covered with mucus layer. In addition, all formulations were able to decrease the TEER of the cell layer significantly (p<0.05). Therefore, both thiolated polymers as nanoparticulate delivery systems represent a promising tool for the oral administration of hydrophilic macromolecules.
Keywords: Adhesion; Chitosan (PubChem CID: CID 21896651); Cytotoxic effects; Dithionitrobenzoic acid (PubChem CID: 6254); Nanoparticles; Permeation enhancement; Polymer synthesis; Sodium borohydride (PubChem CID: 22959485); Thiazolyl blue tetrazolium bromide (MTT) (PubChem CID: 64965); Thioglycolic acid (PubChem CID: 1133); l-Cysteine hydrochloride (PubChem CID: 60960).
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
- Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa.
Dünnhaupt S, Barthelmes J, Hombach J, Sakloetsakun D, Arkhipova V, Bernkop-Schnürch A. Dünnhaupt S, et al. Int J Pharm. 2011 Apr 15;408(1-2):191-9. doi: 10.1016/j.ijpharm.2011.01.060. Epub 2011 Feb 2. Int J Pharm. 2011. PMID: 21295123 - A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Makhlof A, Werle M, Tozuka Y, Takeuchi H. Makhlof A, et al. J Control Release. 2011 Jan 5;149(1):81-8. doi: 10.1016/j.jconrel.2010.02.001. Epub 2010 Feb 6. J Control Release. 2011. PMID: 20138935 - Mutlifunctional nanoparticles prepared from arginine-modified chitosan and thiolated fucoidan for oral delivery of hydrophobic and hydrophilic drugs.
Chen CH, Lin YS, Wu SJ, Mi FL. Chen CH, et al. Carbohydr Polym. 2018 Aug 1;193:163-172. doi: 10.1016/j.carbpol.2018.03.080. Epub 2018 Mar 29. Carbohydr Polym. 2018. PMID: 29773368 - Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems.
Bernkop-Schnürch A, Kast CE, Guggi D. Bernkop-Schnürch A, et al. J Control Release. 2003 Dec 5;93(2):95-103. doi: 10.1016/j.jconrel.2003.05.001. J Control Release. 2003. PMID: 14636716 Review. - Thiomers for oral delivery of hydrophilic macromolecular drugs.
Bernkop-Schnürch A, Hoffer MH, Kafedjiiski K. Bernkop-Schnürch A, et al. Expert Opin Drug Deliv. 2004 Nov;1(1):87-98. doi: 10.1517/17425247.1.1.87. Expert Opin Drug Deliv. 2004. PMID: 16296722 Review.
Cited by
- Improved Bioavailability of Poorly Soluble Drugs through Gastrointestinal Muco-Adhesion of Lipid Nanoparticles.
Tan SLJ, Billa N. Tan SLJ, et al. Pharmaceutics. 2021 Oct 31;13(11):1817. doi: 10.3390/pharmaceutics13111817. Pharmaceutics. 2021. PMID: 34834232 Free PMC article. Review. - Enzyme-Triggered Intestine-Specific Targeting Adhesive Platform for Universal Oral Drug Delivery.
Li Y, Lee JS, Kirtane AR, Li M, Coffey CW 3rd, Hess K, Lopes A, Collins J, Tamang S, Ishida K, Hayward A, Wainer J, Wentworth AJ, Traverso G. Li Y, et al. Adv Healthc Mater. 2023 Oct;12(27):e2301033. doi: 10.1002/adhm.202301033. Epub 2023 Jun 30. Adv Healthc Mater. 2023. PMID: 37314859 Free PMC article. - Acrylated Chitosan Nanoparticles with Enhanced Mucoadhesion.
Eliyahu S, Aharon A, Bianco-Peled H. Eliyahu S, et al. Polymers (Basel). 2018 Jan 23;10(2):106. doi: 10.3390/polym10020106. Polymers (Basel). 2018. PMID: 30966139 Free PMC article. - Strategies for the enhanced intracellular delivery of nanomaterials.
Azevedo C, Macedo MH, Sarmento B. Azevedo C, et al. Drug Discov Today. 2018 May;23(5):944-959. doi: 10.1016/j.drudis.2017.08.011. Epub 2017 Sep 15. Drug Discov Today. 2018. PMID: 28919437 Free PMC article. Review. - Thiolated-Polymer-Based Nanoparticles as an Avant-Garde Approach for Anticancer Therapies-Reviewing Thiomers from Chitosan and Hyaluronic Acid.
Grosso R, de-Paz MV. Grosso R, et al. Pharmaceutics. 2021 Jun 8;13(6):854. doi: 10.3390/pharmaceutics13060854. Pharmaceutics. 2021. PMID: 34201403 Free PMC article. Review.